Lori Shoaf Joins AAOS as Vice President of the Office of Govenment Relations

Lori Shoaf, JD, MA

The American Association of Orthopaedic Surgeons’ (AAOS) welcomes Lori Shoaf, JD, MA, as the new vice president for the Office of Government Relations, which promotes and advocates for the viewpoint of the orthopaedic community. Based in Washington, D.C., Shoaf will oversee the legislative, regulatory and political teams that together identify, analyze and direct health policy activities to position AAOS as the trusted leaders in advancing musculoskeletal health.

Experience

Most recently, Lori Shoaf spent a decade as the executive director of partnerships, advocacy and coalitions at the Blue Cross Blue Shie Association. She also has previous federal government relations experience at member healthcare associations, including the American Society of Plastic Surgeons, the American Association of Neurological Surgeons and the American College of Physicians. In these roles, Shoaf oversaw legislative and regulatory issues, advanced legislative priorities, led initiatives that increased political action committee contributions, and advanced the value of membership, resulting in stronger recruitment and retention.

Nathan Glusenkamp, MA, chief quality and registries officer at AAOS

“I am confident Lori will be a strong leader for the Association as she brings deep experience and proven success leading public sector engagement, congressional relations and outreach, industry affairs, coalition building, and member services, among others. Her background in both physician advocacy and working with private payers brings a fresh perspective on how our team can successfully advocate on behalf of physicians and patients to improve musculoskeletal care.”

With AAOS’ recent implementation of its new 5-year Strategic Plan, Shoaf will be responsible for working closely with her team and surgeon leaders to ensure advocacy efforts align with the Strategic Plan. In particular, she will collaborate with the Advocacy Council, which establishes AAOS’ annual unified advocacy agenda and builds and maintains coalitions with external organizations in orthopaedic surgery and across organized medicine.

“I am honored to be joining an organization with such a strong reputation in Washington and am excited to build upon AAOS’ strong foundation of multi-pronged advocacy,” said Shoaf. “Together, we will contribute to the evolution of member needs at a time when the profession is rapidly changing, and I look forward to working collaboratively to ensure public policy supports the central role of orthopaedic surgeons leading care teams and medical decision making to benefit patients.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.